SB
Sanjiv Bansal
About Sanjiv Bansal
Data last updated:
Sanjiv Bansal is a Director at Khandwa Bio-Tech Private Limited (since 2023), Director at Gainhigh Capital Investments Private Limited (since 2024) and Director at Namedi Hospitals Private Limited (since 2023), and holds 4 more current directorships. The companies operate in Energy and Power, Real Estate and Construction and Healthcare. The 5 current companies with reported revenue have a combined latest revenue of ₹67.62 Cr; the largest is Khandwa Bio-Tech Private Limited at ₹52.86 Cr (FY 2025). Earlier, Sanjiv Bansal was a Director at Praveen Securities And Investments Private Limited (2023–2025) and Director at R.G. Scientific Enterprises Private Limited (1992–2008) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Khandwa Bio-Tech Private Limited U24124MP2008PTC021017 | Director | 18 Nov 2023 | 2008 | ₹52.86 Cr (FY 2025) | Active |
 Gainhigh Capital Investments Private Limited U70109DL2016PTC301464 | Director | 23 Feb 2024 | 2016 | ₹12.82 Cr (FY 2025) | Active |
| Namedi Hospitals Private Limited U85110DL2001PTC110210 | Director | 27 Feb 2023 | 2001 | ₹1.64 Cr (FY 2024) | Active |
| Morgan Ventures Limited L08106DL1986PLC025841 | Director | 17 Jun 2021 | 1986 | ₹23.3 Lakh (FY 2019) | Active |
| Namedi Foods Private Limited U56101DL1996PTC078984 | Director | 17 May 1996 | 1996 | ₹5.9 Lakh (FY 2022) | Active |
| Sankha Diagnostics Llp ACG-7394 | Designated Partner | 23 Apr 2024 | 2024 | Active | |
| Bansal Hospital And Research Centre Private Limited U74899DL1992PTC048305 | Director | 10 Apr 1992 | 1992 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Praveen Securities And Investments Private Limited U66190DL1991PTC044362 | Director | 18 Nov 2023 | 1991 | ₹37.74 Cr (FY 2025) | Active |
| R.G. Scientific Enterprises Private Limited U24236DL1986PTC023504 | Director | 01 Jul 1992 | 1986 | ₹264 Cr (FY 2025) | Active |
| R.B. Medicare Limited U85100DL1993PLC054979 | Director | 25 Aug 1993 | 1993 | Amalgamated | |
| Dn Healthcare Private Limited U24239DL2003PTC121020 | Director | 20 Jun 2003 | 2003 | Strike Off | |
| Express Meditech Private Limited U85194DL2005PTC137642 | Director | 15 Jun 2005 | 2005 | ₹11.7 Lakh (FY 2021) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjiv Bansal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahendra Singh Bora | 08290269 | Khandwa Bio-Tech Private Limited , Gainhigh Capital Investments Private Limited | Director |
| Parkash Chand | 10394614 | Khandwa Bio-Tech Private Limited | Director |
| Hemendra Kotwalwala | 05227275 | Gainhigh Capital Investments Private Limited | Director |
| Naman Bansal | 06380723 | Namedi Hospitals Private Limited , Namedi Foods Private Limited | Director |
| Sandhya Bansal | 00417207 | Namedi Hospitals Private Limited , Namedi Foods Private Limited and 1 more | Director |
| Kuldeep Kumar Dhar | 00299386 | Morgan Ventures Limited | Managing Director |
| Madhu | 09065199 | Morgan Ventures Limited | Director |
| Sriniwas Chandan | Morgan Ventures Limited | Company Secretary | |
| Yogesh Kumar Gupta | 00022200 | Morgan Ventures Limited | Director |
| Sherry Khanna | 02508830 | Sankha Diagnostics Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjiv Bansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjiv Bansal
Sanjiv Bansal currently holds 7 directorships: Khandwa Bio-Tech Private Limited (Director, since 18 Nov 2023, revenue ₹52.86 Cr (FY 2025)); Gainhigh Capital Investments Private Limited (Director, since 23 Feb 2024, revenue ₹12.82 Cr (FY 2025)); Namedi Hospitals Private Limited (Director, since 27 Feb 2023, revenue ₹1.64 Cr (FY 2024)); Morgan Ventures Limited (Director, since 17 Jun 2021, revenue ₹23.3 Lakh (FY 2019)); Namedi Foods Private Limited (Director, since 17 May 1996, revenue ₹5.9 Lakh (FY 2022)); and 2 more.
Sanjiv Bansal was first appointed on 10 Apr 1992 as Director at Bansal Hospital And Research Centre Private Limited. The most recent appointment on record is 23 Apr 2024 at Sankha Diagnostics Llp.
The 5 current companies of Sanjiv Bansal that report revenue have a combined latest revenue of ₹67.62 Cr: Khandwa Bio-Tech Private Limited ₹52.86 Cr (FY 2025); Gainhigh Capital Investments Private Limited ₹12.82 Cr (FY 2025); Namedi Hospitals Private Limited ₹1.64 Cr (FY 2024); Morgan Ventures Limited ₹23.3 Lakh (FY 2019); Namedi Foods Private Limited ₹5.9 Lakh (FY 2022).
Sanjiv Bansal held 5 earlier board appointments: Praveen Securities And Investments Private Limited (Director, 18 Nov 2023 to 04 Jun 2025); R.G. Scientific Enterprises Private Limited (Director, 01 Jul 1992 to 14 Apr 2008); R.B. Medicare Limited (Director, from 25 Aug 1993); Dn Healthcare Private Limited (Director, from 20 Jun 2003); Express Meditech Private Limited (Director, from 15 Jun 2005).
The current boards of Sanjiv Bansal's companies include Mahendra Singh Bora (Khandwa Bio-Tech Private Limited), Parkash Chand (Khandwa Bio-Tech Private Limited), Hemendra Kotwalwala (Gainhigh Capital Investments Private Limited), Naman Bansal (Namedi Hospitals Private Limited), Sandhya Bansal (Namedi Hospitals Private Limited), Kuldeep Kumar Dhar (Morgan Ventures Limited), among others.